Gaurav Burman, the esteemed Director of Dabur International, has taken an important step into the sphere of healthcare innovation by investing in Mitsu, a groundbreaking mental health tech startup. His support signifies a robust endorsement of Mitsu’s mission to revolutionize mental health support, as he acquires a notable 7.5% stake in this promising venture.
Mitsu, registered as Metacog Health Private Limited, has been making waves in the mental health sector by introducing science-backed guided self-therapy programs. These programs are tailored to assist individuals grappling with anxiety and depression, offering a unique and confidential approach to affordable mental health solutions.
This investment by Burman underscores the importance of mental health well-being, as he shares his optimism about Mitsu’s innovative approach to addressing issues that affect a significant portion of the population at various stages in their lives. For Burman, this investment is not merely a business venture but a step towards realizing his goal of nurturing companies that prioritize innovative and human-centric healthcare solutions.
Burman’s involvement with Mitsu goes beyond financial support. He has also joined Mitsu’s board, leveraging his expertise to guide the company towards further innovation and accessibility in mental health care. His unwavering belief in Mitsu dates back to the conceptual stage of the enterprise.
Mitsu, which officially launched its guided self-therapy app in May 2023, has gained popularity on both iOS and Android. The startup is the brainchild of Amit Singh, former CEO of 3M India Ltd, and has garnered impressive support from industry veterans such as Shivashish Chatterjee and Yuvraj Singh, known for DMI Finance, as well as Harpreet Singh Grover, the founder of CoCubes.com.
